Literature DB >> 18182157

Combined localization and real-time functional studies using a GFP-tagged ABCG2 multidrug transporter.

Tamás I Orbán1, László Seres, Csilla Ozvegy-Laczka, N Barry Elkind, Balázs Sarkadi, László Homolya.   

Abstract

ABCG2 is a half-transporter which causes multidrug resistance when overexpressed in tumor cells. Availability of combined localization and functional assays would greatly improve cell biology and drug modulation studies for this transporter. Here we demonstrate that an N-terminally GFP-tagged version of the protein (GFP-G2) can be used to directly monitor ABCG2 expression, dimerization, localization and function in living cells. GFP-G2 is fully functional when tested for drug-stimulated ATPase activity, vesicular transport assay, subcellular localization or cell surface epitope conformational changes. By measuring both GFP and Hoechst 33342 dye fluorescence in HEK-293 cells, we provide evidence that a real-time transport assay can be reliably applied to identify ABCG2 substrates, transport modulators, as well as to monitor the cellular functions of this multidrug transporter protein. This approach also avoids the need of cloning, drug selection or other further separation or characterization of the transgene-expressing cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182157     DOI: 10.1016/j.bbrc.2007.12.172

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Fluorescence resonance energy transfer (FRET) analysis demonstrates dimer/oligomer formation of the human breast cancer resistance protein (BCRP/ABCG2) in intact cells.

Authors:  Zhanglin Ni; Michelle E Mark; Xiaokun Cai; Qingcheng Mao
Journal:  Int J Biochem Mol Biol       Date:  2010

2.  Expression of RecA and cell-penetrating peptide (CPP) fusion protein in bacteria and in mammalian cells.

Authors:  Xiubao Chang; Yuexian Hou
Journal:  Int J Biochem Mol Biol       Date:  2018-02-08

3.  Human Breast Cancer Stem Cells Have Significantly Higher Rate of Clathrin-Independent and Caveolin-Independent Endocytosis than the Differentiated Breast Cancer Cells.

Authors:  Kanagaraj Palaniyandi; Barbara A Pockaj; Sandra J Gendler; Xiu-Bao Chang
Journal:  J Cancer Sci Ther       Date:  2012-07-26

4.  Reliable transgene-independent method for determining Sleeping Beauty transposon copy numbers.

Authors:  Orsolya Kolacsek; Virág Krízsik; Anita Schamberger; Zsuzsa Erdei; Agota Apáti; György Várady; Lajos Mátés; Zsuzsanna Izsvák; Zoltán Ivics; Balázs Sarkadi; Tamás I Orbán
Journal:  Mob DNA       Date:  2011-03-03

5.  Interaction of crown ethers with the ABCG2 transporter and their implication for multidrug resistance reversal.

Authors:  Marija Mioč; Ágnes Telbisz; Katarina Radman; Branimir Bertoša; Tatjana Šumanovac; Balázs Sarkadi; Marijeta Kralj
Journal:  Histochem Cell Biol       Date:  2022-06-01       Impact factor: 2.531

6.  Effects of putative catalytic base mutation E211Q on ABCG2-mediated methotrexate transport.

Authors:  Yue-xian Hou; Chang-Zhong Li; Kanagaraj Palaniyandi; Paul M Magtibay; Laszlo Homolya; Balazs Sarkadi; Xiu-bao Chang
Journal:  Biochemistry       Date:  2009-09-29       Impact factor: 3.162

7.  Localization and substrate selectivity of sea urchin multidrug (MDR) efflux transporters.

Authors:  Tufan Gökirmak; Joseph P Campanale; Lauren E Shipp; Gary W Moy; Houchao Tao; Amro Hamdoun
Journal:  J Biol Chem       Date:  2012-11-02       Impact factor: 5.157

8.  Structure and function of ABCG2-rich extracellular vesicles mediating multidrug resistance.

Authors:  Vicky Goler-Baron; Yehuda G Assaraf
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

Review 9.  Pharmacological correction of misfolding of ABC proteins.

Authors:  Elena L Rudashevskaya; Thomas Stockner; Michael Trauner; Michael Freissmuth; Peter Chiba
Journal:  Drug Discov Today Technol       Date:  2014-06

10.  Functional Cooperativity between ABCG4 and ABCG1 Isoforms.

Authors:  Zoltán Hegyi; László Homolya
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.